SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
16.41
+0.41 (2.56%)
At close: Aug 6, 2025, 4:00 PM
16.39
-0.02 (-0.12%)
After-hours: Aug 6, 2025, 5:48 PM EDT
Sage Therapeutics Market Cap
SI-BONE has a market cap or net worth of $699.30 million as of August 6, 2025. Its market cap has increased by 2.18% in one year.
Market Cap
699.30M
Enterprise Value
590.69M
1-Year Change
2.18%
Ranking
Category
Stock Price
$16.41
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $218.80M to $699.30M, an increase of 219.60%. That is a compound annual growth rate of 18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 681.83M | 15.96% |
| Dec 31, 2024 | 587.97M | -30.84% |
| Dec 29, 2023 | 850.12M | 81.20% |
| Dec 30, 2022 | 469.15M | -36.93% |
| Dec 31, 2021 | 743.81M | -23.13% |
| Dec 31, 2020 | 967.59M | 79.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.35B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |